X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (135) 135
oncology (108) 108
female (91) 91
index medicus (88) 88
breast cancer (66) 66
middle aged (66) 66
aged (63) 63
cancer (45) 45
male (44) 44
adult (40) 40
prognosis (40) 40
breast neoplasms - drug therapy (37) 37
breast neoplasms - pathology (36) 36
chemotherapy (29) 29
chemistry (26) 26
metallurgy (26) 26
beer (25) 25
biochemistry (25) 25
breast neoplasms - metabolism (25) 25
compositions or test papers therefor (25) 25
condition-responsive control in microbiological orenzymological processes (25) 25
enzymology (25) 25
investigating or analysing materials by determining theirchemical or physical properties (25) 25
measuring (25) 25
measuring or testing processes involving enzymes, nucleicacids or microorganisms (25) 25
microbiology (25) 25
mutation or genetic engineering (25) 25
physics (25) 25
processes of preparing such compositions (25) 25
spirits (25) 25
testing (25) 25
trastuzumab (25) 25
vinegar (25) 25
wine (25) 25
animals (24) 24
organic chemistry (24) 24
peptides (23) 23
treatment outcome (23) 23
antineoplastic agents - therapeutic use (22) 22
metastasis (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
immunohistochemistry (21) 21
tumors (21) 21
breast neoplasms - genetics (20) 20
therapy (20) 20
aged, 80 and over (19) 19
cell line, tumor (18) 18
medicine & public health (18) 18
antineoplastic agents - pharmacology (16) 16
mice (16) 16
càncer (15) 15
prospective studies (15) 15
research (15) 15
survival analysis (15) 15
hematology, oncology and palliative medicine (14) 14
her2 (14) 14
neoplasms - drug therapy (14) 14
receptor, erbb-2 - metabolism (14) 14
activation (13) 13
antibodies, monoclonal - therapeutic use (13) 13
antibodies, monoclonal, humanized (13) 13
growth-factor receptor (13) 13
apoptosis (12) 12
breast (12) 12
expression (12) 12
lung neoplasms - pathology (12) 12
neoplasm staging (12) 12
receptor, epidermal growth factor - antagonists & inhibitors (12) 12
survival (12) 12
article (11) 11
dose-response relationship, drug (11) 11
neoplasm metastasis (11) 11
spain (11) 11
analysis (10) 10
biomarkers, tumor - metabolism (10) 10
cell biology (10) 10
clinical trials as topic (10) 10
gene expression (10) 10
lung neoplasms - genetics (10) 10
pathology (10) 10
trial (10) 10
apoptosis - drug effects (9) 9
blotting, western (9) 9
breast-cancer (9) 9
gene expression profiling (9) 9
gene expression regulation, neoplastic (9) 9
in situ hybridization, fluorescence (9) 9
mama (9) 9
mutation (9) 9
patients (9) 9
retrospective studies (9) 9
risk (9) 9
signal transduction - drug effects (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
aromatase inhibitors (8) 8
biomarkers, tumor - genetics (8) 8
carcinoma-cells (8) 8
chemotherapy, adjuvant (8) 8
cohort studies (8) 8
doxorubicin (8) 8
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (283) 283
Spanish (19) 19
French (12) 12
German (7) 7
Catalan (3) 3
Chinese (2) 2
Portuguese (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 04/2016, Volume 7, Issue 1, pp. 11199 - 11199
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 4, pp. 350 - 357
Journal Article
Genome Medicine, ISSN 1756-994X, 03/2018, Volume 10, Issue 1, pp. 25 - 8
While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important... 
MUTATIONS | DATABASE | LANDSCAPE | DRUGS | GENETICS & HEREDITY | Genetic aspects | Research | Gene mutations | Carcinogenesis | Genomics | Cancer | Cancer genome interpreter | Neoplasms
Journal Article
Scientific Reports, ISSN 2045-2322, 01/2017, Volume 7, Issue 1, p. 41309
A subset of HER2+ breast cancer patients manifest clinical resistance to trastuzumab. Recently, miR-26a and miR-30b have been identified as trastuzumab... 
BREAST-CANCER | CYTOCHROME-C | LAPATINIB | CELLS | ACTIVATION | INHIBITION | MECHANISM | HERCEPTIN | PATHWAY | MULTIDISCIPLINARY SCIENCES | ESTROGEN-RECEPTOR | Breast cancer | ErbB-2 protein | Trastuzumab | Cell lines | Aspectes genètics | Tractament | Càncer | Mama
Journal Article
Journal Article
Nature Cell Biology, ISSN 1465-7392, 08/2009, Volume 11, Issue 8, pp. 943 - 950
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 2992 - 13
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1594 - 1600
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 26, pp. 3226 - 3227
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2017, Volume 23, Issue 22, pp. 7006 - 7019
Journal Article
Nucleic acids research, 02/2018, Volume 46, Issue 3, p. e15
Small non-coding RNAs (sncRNAs) are highly abundant molecules that regulate essential cellular processes and are classified according to sequence and... 
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2001, Volume 93, Issue 24, pp. 1830 - 1832
Journal Article
Nature Communications, ISSN 2041-1723, 12/2016, Volume 7, Issue 1, p. 13665
Blockade of the epidermal growth factor receptor (EGFR) with the monoclonal antibodies cetuximab or panitumumab is effective in a subset of colorectal cancers... 
HETEROGENEITY | THERAPY | AMPLIFICATION | INSTABILITY | ALIGNMENT | MULTIDISCIPLINARY SCIENCES | RESISTANCE | KRAS | CLONAL DYNAMICS | CELL-LINES | IDENTIFICATION
Journal Article